{"doi":"10.17615/7mzq-bf22","title":"TIR domains of plant immune receptors are NAD+-cleaving enzymes that promote cell death","abstract":"Plant nucleotide-binding leucine-rich repeat (NLR) immune receptors activate cell death and confer disease resistance by unknown mechanisms. We demonstrate that plant Toll/interleukin-1 receptor (TIR) domains of NLRs are enzymes capable of degrading nicotinamide adenine dinucleotide in its oxidized form (NAD+). Both cell death induction and NAD+ cleavage activity of plant TIR domains require known self-association interfaces and a putative catalytic glutamic acid that is conserved in both bacterial TIR NAD+-cleaving enzymes (NADases) and the mammalian SARM1 (sterile alpha and TIR motif containing 1) NADase. We identify a variant of cyclic adenosine diphosphate ribose as a biomarker of TIR enzymatic activity. TIR enzymatic activity is induced by pathogen recognition and functions upstream of the genes enhanced disease susceptibility 1 (EDS1) and N requirement gene 1 (NRG1), which encode regulators required for TIR immune function. Thus, plant TIR-NLR receptors require NADase function to transduce recognition of pathogens into a cell death response.","journal":"UNC Libraries","year":2022,"id":268652,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":24,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9557,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2022-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":931439,"name":"F. Monteiro","orcid":null,"position":1,"is_corresponding":false},{"id":931440,"name":"A. DiAntonio","orcid":null,"position":2,"is_corresponding":false},{"id":931441,"name":"J. Milbrandt","orcid":null,"position":3,"is_corresponding":false},{"id":835417,"name":"J.L. Dangl","orcid":null,"position":4,"is_corresponding":false},{"id":10143,"name":"Y. Sasaki","orcid":null,"position":5,"is_corresponding":false},{"id":931442,"name":"R.G. Anderson","orcid":null,"position":6,"is_corresponding":false},{"id":444642,"name":"E.-H. Chung","orcid":null,"position":7,"is_corresponding":false},{"id":931443,"name":"K. Essuman","orcid":null,"position":8,"is_corresponding":false},{"id":836984,"name":"M.T. Nishimura","orcid":null,"position":9,"is_corresponding":false},{"id":931444,"name":"E.O. Nishimura","orcid":null,"position":10,"is_corresponding":false},{"id":931438,"name":"L. Wan","orcid":null,"position":0,"is_corresponding":true}],"reference_count":0,"raw_metadata":null,"created_at":"2026-07-19T00:27:14.088663Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}